We are live on ! Find out more
CCIA

Campbell & Co Investment Adviser Portfolio holdings

AUM $1.91B
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
-2.79%
1 Year Est. Return
+17.57%
3 Year Est. Return
+30.96%
5 Year Est. Return
+33.24%
10 Year Est. Return
+189.91%
AUM
$1.3B
AUM Growth
-$47.1M
Cap. Flow
+$24.6M
Cap. Flow %
1.9%
Top 10 Hldgs %
6.85%
Holding
1,438
New
382
Increased
281
Reduced
354
Closed
421

Top Buys

Rank Stock Value
1
FAST icon
Fastenal
FAST
+$11M
2
HCA icon
HCA Healthcare
HCA
+$9.65M
3
NVS icon
Novartis
NVS
+$9.58M
4
GWW icon
W.W. Grainger
GWW
+$8.68M
5
MKTX icon
MarketAxess Holdings
MKTX
+$8.16M

Top Sells

Rank Stock Value
1
WDAY icon
Workday
WDAY
+$11.1M
2
PEP icon
PepsiCo
PEP
+$8.45M
3
MSCI icon
MSCI
MSCI
+$8M
4
EG icon
Everest Group
EG
+$7.88M
5
APH icon
Amphenol
APH
+$7.7M

Sector Composition

Rank Sector Weight
1 Financials 15.84%
2 Technology 15.15%
3 Industrials 14.45%
4 Healthcare 12.78%
5 Consumer Discretionary 11.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WDAY icon
1401
Workday
WDAY
$45.7B
– –
-45,418
Closed -$11.1M
WGO icon
1402
Winnebago Industries
WGO
$768M
– –
-16,777
Closed -$975K
WIT icon
1403
Wipro
WIT
$16.3B
– –
-166,994
Closed -$541K
WK icon
1404
Workiva
WK
$3.79B
– –
-13,694
Closed -$1.08M
WKC icon
1405
World Kinect Corp
WKC
$1.82B
– –
-19,259
Closed -$595K
WMT icon
1406
Walmart Inc
WMT
$857B
– –
-9,642
Closed -$779K
WNC icon
1407
Wabash National
WNC
$531M
– –
-49,426
Closed -$948K
WNS
1408
DELISTED
WNS Holdings
WNS
– –
-8,729
Closed -$460K
WPM icon
1409
Wheaton Precious Metals
WPM
$64.9B
– –
-59,491
Closed -$3.63M
WSBC icon
1410
WesBanco
WSBC
$3.71B
– –
-19,019
Closed -$566K
WSC icon
1411
WillScot Mobile Mini Holdings
WSC
$3.29B
– –
-7,385
Closed -$278K
WSFS icon
1412
WSFS Financial
WSFS
$3.97B
– –
-6,722
Closed -$343K
WSO icon
1413
Watsco Inc
WSO
$13.1B
– –
-840
Closed -$413K
WST icon
1414
West Pharmaceutical
WST
$26.1B
– –
-904
Closed -$271K
WTRG icon
1415
Essential Utilities
WTRG
$11.2B
– –
-159,738
Closed -$6.16M
WTW icon
1416
Willis Towers Watson
WTW
$27.3B
– –
-10,559
Closed -$3.11M
XENE icon
1417
Xenon Pharmaceuticals
XENE
$3.58B
– –
-7,339
Closed -$289K
XNCR icon
1418
Xencor
XNCR
$1.77B
– –
-24,363
Closed -$490K
XPEL icon
1419
XPEL
XPEL
$1.2B
– –
-10,304
Closed -$447K
XRAY icon
1420
Dentsply Sirona
XRAY
$1.87B
– –
-15,599
Closed -$422K
XYL icon
1421
Xylem
XYL
$24B
– –
-2,247
Closed -$303K
YALA
1422
Yalla Group
YALA
$832M
– –
-55,136
Closed -$250K
YETI icon
1423
Yeti Holdings
YETI
$3.09B
– –
-150,276
Closed -$6.17M
YUM icon
1424
Yum! Brands
YUM
$37.8B
– –
-23,296
Closed -$3.25M
ZEUS
1425
DELISTED
Olympic Steel
ZEUS
– –
-15,017
Closed -$586K

Similar funds

Campbell & Co Investment Adviser's Q4 2024 Portfolio in Review

As of Q4 2024, Campbell & Co Investment Adviser held 1,438 positions worth $1.3B, down 3.5% from $1.34B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.

Campbell & Co Investment Adviser's Q4 2024 filing shows 382 new, 281 increased, 354 reduced and 421 closed positions. Its largest new stake was Fastenal: 282,302 shares worth $10.2M. The largest sale was Workday, an estimated $11.1M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.

  • Campbell & Co Investment Adviser's largest Q4 2024 buy was Fastenal: 282,302 shares worth $10.2M.
  • Campbell & Co Investment Adviser added most to HCA Healthcare in Q4 2024, an estimated $9.65M increase.
  • Campbell & Co Investment Adviser's biggest Q4 2024 reduction was PepsiCo, cutting an estimated $8.45M.
  • Campbell & Co Investment Adviser fully exited Workday in Q4 2024, selling an estimated $11.1M.
  • Campbell & Co Investment Adviser's ten largest holdings make up 6.8% of its $1.3B portfolio in Q4 2024.
  • Campbell & Co Investment Adviser opened 382 new positions and closed 421 in Q4 2024.
  • Campbell & Co Investment Adviser's portfolio value fell 3.5% quarter-over-quarter to $1.3B.

Based on Campbell & Co Investment Adviser's 13F filing for Q4 2024, filed 10 Feb 2025.